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The four traditional criteria for newborn screening originated in 1963 with the
development of the Guthrie test for phenylketonuria (PKU). The first criterion was
that there be a disease, not simply a laboratory variation; for example, PKU and
congenital hypothyroidism are examples of laboratory abnormalities which are
associatedwith pathological states. The second criterion was that the disease should
cause significant problems, such as mental retardation and early death. The third
criterion hasbeen that the problems caused bythe disease be amenable to treatment
directed at preventing symptoms. The fourth criterion was that a marker for the
disease be identifiable in the newborn prior to the appearance of symptoms and
before the biochemical abnormalities ofthe disease produce irreversible damage.
Over time, the strict application ofthose classical criteria has been compromised,
so thatwe no longer require that the intervention totally eliminate the appearance of
symptoms. Instead, it is acceptable if there are some benefits from early detection
even if complete prevention of disease is not possible. Based on the new relaxed
treatment criterion, we are now screening for cystic fibrosis and sickle-cell disease in
many states. The course ofboth diseases many, however, be dramatically changed by
newborn screening. In patients with cystic fibrosis, severe morbidity and mortality
within the firstyearoflife maybe avoided through early intervention with antibiotics
and pancreatic enzymes. Similarly, for sickle-cell patients, early initiation of antibi-
otictherapycanprevent death fromoverwhelmingbacterial infection duringinfancy.
These diseases illustrate the importance of newborn screening even for diseases in
which symptoms cannot be completely prevented by early detection and interven-
tion. Although the long-term consequences of these disorders are not altered by
early identification and treatment, the benefits are considered adequate reasons for
screening.
Newborn screening is not conducted in a vacuum. We must be conscious of the
negative effects of the screening process. One of the most troubling effects for the
family is anxiety, which is generated by identification in the newborn ofdiseases for
which there may be no effective treatment. Anxiety is also generated by the
false-positive results which inevitably occur in newborn screening. Is this conse-
quence counterproductive, relative to the overall benefits to be obtained from
newborn screening? What aboutthe family'sperception ofthe childwho is identified
by newborn screening as suffering from a disorder, particularlywhen the infant does
not truly have the disorder? Is the family's perception of the child changed in a way
thatwill have serious negative consequences for the child?
One can certainly ask this question with regard to carrier identification. Children
known tobe sickle-cell carriers maybeviewed quite differentlyfrom childrenwho do
not carry the sickle globin gene. This attitude may also be true for identification of
other, seemingly benign carrier states, such as that for PKU. The situation could
result in stigmatization of the child, not only by the family but also by society. Such
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stigmatization might interfere with the ability to obtain health insurance and life
insurance; it could even extend to school andjob discrimination.
The question I raise is, are we going too far or are we in danger of going too far
with implementation of new technologies in newborn screening? I do not know the
answer. But I do know that, as we continue, we will be called upon increasingly to
consider what we are doing to families and what we are doing to society. We will be
questioned by health insurers and others with increasing intensity. It is not too soon
for us to begin examining not only the technologies but the consequences of the
technologies.